Regulator of G protein signaling 6 mediates doxorubicin-induced ATM and p53 activation by a reactive oxygen species-dependent mechanism.

Doxorubicin (DXR), among the most widely used cancer chemotherapy agents, promotes cancer cell death via activation of ataxia telangiectasia mutated (ATM) and the resultant upregulation of tumor suppressor p53. The exact mechanism by which DXR activates ATM is not fully understood. Here, we discovered a novel role for regulator of G protein signaling 6 (RGS6) in mediating activation of ATM and p53 by DXR. RGS6 was robustly induced by DXR, and genetic loss of RGS6 dramatically impaired DXR-induced activation of ATM and p53, as well as its in vivo apoptotic actions in heart. The ability of RGS6 to promote p53 activation in response to DXR was independent of RGS6 interaction with G proteins but required ATM. RGS6 mediated activation of ATM and p53 by DXR via a reactive oxygen species (ROS)-dependent and DNA damage-independent mechanism. This mechanism represents the primary means by which DXR promotes activation of the ATM-p53 apoptosis pathway that underlies its cytotoxic activity. Our findings contradict the canonical theories that DXR activates ATM primarily by promoting DNA damage either directly or indirectly (via ROS) and that RGS6 function is mediated by its interactions with G proteins. These findings reveal a new mechanism for the chemotherapeutic actions of DXR and identify RGS6 as a novel target for cancer chemotherapy.

[1]  G. Mills,et al.  ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer. , 2011, Cancer research.

[2]  Mark E. Anderson,et al.  RGS6, a Modulator of Parasympathetic Activation in Heart , 2010, Circulation research.

[3]  R. Askeland,et al.  Regulator of G Protein Signaling 6 (RGS6) Induces Apoptosis via a Mitochondrial-dependent Pathway Not Involving Its GTPase-activating Protein Activity* , 2010, The Journal of Biological Chemistry.

[4]  M. Lavin,et al.  ATM Activation by Oxidative Stress , 2010, Science.

[5]  S. Elledge,et al.  The DNA damage response: making it safe to play with knives. , 2010, Molecular cell.

[6]  I. Komuro,et al.  Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. , 2009, Journal of molecular and cellular cardiology.

[7]  J. Bartek,et al.  The DNA-damage response in human biology and disease , 2009, Nature.

[8]  D. Dinh,et al.  Doxorubicin-mediated apoptosis in glioma cells requires NFAT3 , 2009, Cellular and Molecular Life Sciences.

[9]  Liu,et al.  Acute Doxorubicin Cardiotoxicity Is Associated With p53-Induced Inhibition of the Mammalian Target of Rapamycin Pathway , 2009, Circulation.

[10]  T. K. Harden,et al.  Crystal structure of the multifunctional Gβ5–RGS9 complex , 2008, Nature Structural &Molecular Biology.

[11]  O. Mian,et al.  Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice , 2005, Molecular and Cellular Biochemistry.

[12]  V. Arshavsky,et al.  R7BP, a Novel Neuronal Protein Interacting with RGS Proteins of the R7 Family* , 2005, Journal of Biological Chemistry.

[13]  S. Lees-Miller,et al.  Doxorubicin Activates ATM-dependent Phosphorylation of Multiple Downstream Targets in Part through the Generation of Reactive Oxygen Species* , 2004, Journal of Biological Chemistry.

[14]  L. Liotta,et al.  A Functional Polymorphism in RGS6 Modulates the Risk of Bladder Cancer , 2004, Cancer Research.

[15]  R. Hamdy,et al.  Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice , 2004 .

[16]  Huichen Wang,et al.  DNA damage checkpoint control in cells exposed to ionizing radiation , 2003, Oncogene.

[17]  R. Fisher,et al.  Human RGS6 Gene Structure, Complex Alternative Splicing, and Role of N Terminus and G Protein γ-Subunit-like (GGL) Domain in Subcellular Localization of RGS6 Splice Variants* , 2003, Journal of Biological Chemistry.

[18]  M. Kastan,et al.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.

[19]  R. Fisher,et al.  RGS6 Interacts with SCG10 and Promotes Neuronal Differentiation , 2002, The Journal of Biological Chemistry.

[20]  S. T. Kim,et al.  ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. , 2001, Genes & development.

[21]  E M Ross,et al.  GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. , 2000, Annual review of biochemistry.

[22]  Y. Shiloh,et al.  Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Farquhar,et al.  Divergence of RGS proteins: evidence for the existence of six mammalian RGS subfamilies. , 1999, Trends in biochemical sciences.

[24]  E. Rojas,et al.  Single cell gel electrophoresis assay: methodology and applications. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[25]  Yoichi Taya,et al.  ATM associates with and phosphorylates p53: mapping the region of interaction , 1999, Nature Genetics.

[26]  Y Taya,et al.  Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.

[27]  V. Slepak,et al.  Identification of the Gβ5-RGS7 Protein Complex in the Retina☆ , 1998 .

[28]  G. Evan,et al.  A matter of life and cell death. , 1998, Science.

[29]  A. Gilman,et al.  Mammalian RGS Proteins: Barbarians at the Gate* , 1998, The Journal of Biological Chemistry.

[30]  Y Taya,et al.  DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.

[31]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[32]  J. Thorner,et al.  RGS Proteins and Signaling by Heterotrimeric G Proteins* , 1997, The Journal of Biological Chemistry.

[33]  Scott W. Lowe,et al.  p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.

[34]  F. Zunino,et al.  DNA topoisomerase-trapping antitumour drugs. , 1992, European journal of cancer.

[35]  L. Liu,et al.  Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. , 1984, Science.

[36]  K. C. Majumdar,et al.  Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents. , 1977, Biochemical and biophysical research communications.

[37]  S. Carter.  Adriamycin-a review. , 1975, Journal of the National Cancer Institute.